• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Arctic Bioscience

Less than 1K followers

ABS

Euronext Growth Oslo

Food & Beverage

Consumer Goods & Services

Overview
Ownership
Investor consensus

Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical products and dietary supplements based on bioactive marine raw materials. The company is developing HRO350, a novel drug candidate for the treatment of patients with mild to moderate psoriasis. Dietary supplements are sold globally as both bulk ingredients and finished products under the ROMEGA brand, to both companies and private customers.

Read more
Market cap
-
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
27.8.
2026

Interim report Q2'26

All
Press releases
ShowingAll content types

Regulatory press release5/27/2026, 10:31 AM

Arctic Bioscience - Minutes of the Annual General Meeting

Arctic Bioscience
Regulatory press release5/13/2026, 7:00 AM

Arctic Bioscience - Notice of Annual General Meeting on 27 May 2026

Arctic Bioscience
Regulatory press release5/8/2026, 8:35 AM

ABS: Arctic Bioscience presents HeROPA data at EADV in Athens

Arctic Bioscience

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release5/8/2026, 8:35 AM

Arctic Bioscience AS: Arctic Bioscience presents HeROPA data at EADV in Athens

Arctic Bioscience
Regulatory press release5/7/2026, 5:30 AM

Arctic Bioscience - Annual report 2025

Arctic Bioscience
Regulatory press release4/30/2026, 5:00 AM

Arctic Bioscience AS: Arctic Bioscience - 78% growth in Nutra revenues

Arctic Bioscience
Regulatory press release4/24/2026, 7:30 AM

Arctic Bioscience AS: Arctic Bioscience - Invitation to presentation of Q1 2026 operational update

Arctic Bioscience
Regulatory press release4/1/2026, 8:56 AM

Arctic Bioscience AS: Arctic Bioscience - Primary insiders who have provided bank guarantee

Arctic Bioscience
Regulatory press release4/1/2026, 8:40 AM

Arctic Bioscience AS: Arctic Bioscience - New long-term financing

Arctic Bioscience
Regulatory press release3/19/2026, 11:49 AM

Arctic Bioscience AS: Arctic Bioscience - New peer-reviewed study shows herring roe phospholipids stimulate anti-inflammatory pathways in cells

Arctic Bioscience
Regulatory press release2/26/2026, 6:00 AM

Arctic Bioscience AS: Arctic Bioscience - Q4 2025 Operational update - Positive outlook for 2026

Arctic Bioscience
Regulatory press release2/23/2026, 12:09 PM

Arctic Bioscience AS: Arctic Bioscience - Invitation to presentation of Q4 2025 operational update

Arctic Bioscience
Regulatory press release1/29/2026, 7:30 AM

Arctic Bioscience AS: Arctic Bioscience invited to present at the Glaucoma 360 New Horizons Forum

Arctic Bioscience
Regulatory press release12/18/2025, 8:33 AM

ABS: Financial calendar

Arctic Bioscience
Regulatory press release12/17/2025, 10:37 AM

Arctic Bioscience AS: Arctic Bioscience - Share capital increase registered

Arctic Bioscience
Regulatory press release12/12/2025, 3:05 PM

Arctic Bioscience AS: Arctic Bioscience - Board approval of share capital increase related to conversion of debt

Arctic Bioscience
Regulatory press release12/9/2025, 7:29 AM

Arctic Bioscience AS: Arctic Bioscience - Exercise of right to convert debt and issuance of shares

Arctic Bioscience
Regulatory press release11/11/2025, 11:03 AM

Arctic Bioscience AS: Arctic Bioscience - Minutes of the Extraordinary General Meeting

Arctic Bioscience
Regulatory press release11/10/2025, 6:00 AM

Arctic Bioscience AS: Arctic Bioscience - Q3 2025 Operational update - Significant results on systemic inflammation

Arctic Bioscience
Regulatory press release11/7/2025, 7:00 AM

Arctic Bioscience AS: Arctic Bioscience - Invitation to presentation of Q3 operational update and HeROPA-analyses results

Arctic Bioscience